RT Journal Article
SR Electronic
T1 ICU and ventilator mortality among critically ill adults with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.23.20076737
DO 10.1101/2020.04.23.20076737
A1 Auld, Sara
A1 Caridi-Scheible, Mark
A1 Blum, James M.
A1 Robichaux, Chad J.
A1 Kraft, Colleen S.
A1 Jacob, Jesse T.
A1 Jabaley, Craig S.
A1 Carpenter, David
A1 Kaplow, Roberta
A1 Hernandez, Alfonso C.
A1 Adelman, Max W.
A1 Martin, Gregory S.
A1 Coopersmith, Craig M.
A1 Murphy, David J.
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/04/26/2020.04.23.20076737.abstract
AB We report preliminary data from a cohort of adults admitted to COVID-designated intensive care units from March 6 through April 17, 2020 across an academic healthcare system. Among 217 critically ill patients, mortality for those who required mechanical ventilation was 29.7% (49/165), with 8.5% (14/165) of patients still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 25.8% (56/217), and 40.1% (87/217) patients have survived to hospital discharge. Despite multiple reports of mortality rates exceeding 50% among critically ill adults with COVID-19, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the following grants: NIH/NIAID K23 AI134182 (SCA), NIH/CTSA UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesInvestigators may contact the authors regarding the availability of data.